Please use this identifier to cite or link to this item: https://covid-19.conacyt.mx/jspui/handle/1000/719
Neutralizing Antibodies against SARS-CoV-2 and Other Human Coronaviruses
Jiang, S
Hillyer, C
Du, L
Acceso Abierto
Atribución-NoComercial-SinDerivadas
Coronavirus (CoV) disease 2019 (COVID-19) caused by severe acute respiratory syndrome (SARS)-CoV-2 (also known as 2019-nCoV) is threatening global public health, social stability, and economic development. To meet this challenge, this article discusses advances in the research and development of neutralizing antibodies (nAbs) for the prevention and treatment of infection by SARS-CoV-2 and other human CoVs.
Trends in Immunology
2020
Preimpreso
https://coronavirus.1science.com/item/80f1d64a69f6f901b7fba5fba14f9e0b9b5f2df5
Inglés
VIRUS RESPIRATORIOS
Appears in Collections:Artículos científicos

Upload archives


File SizeFormat 
101541.pdf1.05 MBAdobe PDFView/Open